Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study
- PMID: 15136304
- DOI: 10.1001/archinte.164.9.963
Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study
Abstract
Background: There is limited information about risk factors for venous thromboembolism (VTE) in acutely ill hospitalized general medical patients.
Methods: An international, randomized, double-masked, placebo-controlled trial (MEDENOX) has previously been conducted in 1102 acutely ill, immobilized general medical patients and has shown the efficacy of using a low-molecular-weight heparin, enoxaparin sodium, in preventing thrombosis. We performed logistic regression analysis to evaluate the independent nature of different types of acute medical illness (heart failure, respiratory failure, infection, rheumatic disorder, and inflammatory bowel disease) and predefined factors (chronic heart and respiratory failure, age, previous VTE, and cancer) as risk factors for VTE.
Results: The primary univariate analysis showed that the presence of an acute infectious disease, age older than 75 years, cancer, and a history of VTE were statistically significantly associated with an increased VTE risk. Multiple logistic regression analysis indicated that these factors were independently associated with VTE.
Conclusions: Several independent risk factors for VTE were identified. These findings allow recognition of individuals at increased risk of VTE and will contribute to the formulation of an evidence-based risk assessment model for thromboprophylaxis in hospitalized general medical patients.
Comment in
-
Risk factors for venous thromboembolism.Arch Intern Med. 2004 Nov 22;164(21):2386. doi: 10.1001/archinte.164.21.2386-b. Arch Intern Med. 2004. PMID: 15557421 No abstract available.
Similar articles
-
Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients.Thromb Haemost. 2005 Oct;94(4):750-9. Thromb Haemost. 2005. PMID: 16270626 Review.
-
Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada.Thromb Res. 2007;119(2):145-55. doi: 10.1016/j.thromres.2006.01.011. Epub 2006 Mar 3. Thromb Res. 2007. PMID: 16516275
-
Economic evaluation of enoxaparin as prophylaxis against venous thromboembolism in seriously ill medical patients: a US perspective.Am J Manag Care. 2002 Dec;8(12):1082-8. Am J Manag Care. 2002. PMID: 12500884 Clinical Trial.
-
Preventing venous thromboembolism in acute medical patients.QJM. 2004 Dec;97(12):797-801. doi: 10.1093/qjmed/hch128. QJM. 2004. PMID: 15569811
-
Venous thromboembolism in the medically ill patient: a call to action.Int J Clin Pract. 2005 May;59(5):555-61. doi: 10.1111/j.1368-5031.2005.00529.x. Int J Clin Pract. 2005. PMID: 15857352 Review.
Cited by
-
Venous thromboembolism in medical patients during hospitalisation and 3 months after hospitalisation: a prospective observational study.BMJ Open. 2016 Aug 3;6(8):e012346. doi: 10.1136/bmjopen-2016-012346. BMJ Open. 2016. PMID: 27489158 Free PMC article.
-
[Thrombosis prophylaxis in geriatric patients].Z Gerontol Geriatr. 2012 Apr;45(3):231-40; quiz 241. doi: 10.1007/s00391-012-0294-6. Z Gerontol Geriatr. 2012. PMID: 22441411 German.
-
Risk stratification for hospital-acquired venous thromboembolism in medical patients (RISE): Protocol for a prospective cohort study.PLoS One. 2022 May 24;17(5):e0268833. doi: 10.1371/journal.pone.0268833. eCollection 2022. PLoS One. 2022. PMID: 35609087 Free PMC article.
-
Venous Thromboembolism Prophylaxis and Risk for Acutely Medically Ill Patients Stratified by Different Ages and Renal Disease Status.Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029618823287. doi: 10.1177/1076029618823287. Clin Appl Thromb Hemost. 2019. PMID: 30808218 Free PMC article.
-
Heparin based prophylaxis to prevent venous thromboembolic events and death in patients with cancer - a subgroup analysis of CERTIFY.BMC Cancer. 2011 Jul 26;11:316. doi: 10.1186/1471-2407-11-316. BMC Cancer. 2011. PMID: 21791091 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical